CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 96 filers reported holding CYTOSORBENTS CORP in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $25,000 | -86.1% | 11,464 | -79.7% | 0.00% | -81.2% |
| Q1 2022 | $180,000 | +130.8% | 56,554 | +202.9% | 0.02% | +100.0% |
| Q4 2021 | $78,000 | -92.1% | 18,671 | -84.6% | 0.01% | -91.6% |
| Q3 2021 | $982,000 | +9.1% | 120,879 | +1.4% | 0.10% | +11.8% |
| Q2 2021 | $900,000 | -13.8% | 119,181 | -0.9% | 0.08% | -27.4% |
| Q1 2021 | $1,044,000 | +37.2% | 120,295 | +26.0% | 0.12% | +39.3% |
| Q4 2020 | $761,000 | +56.3% | 95,448 | +56.4% | 0.08% | +20.0% |
| Q3 2020 | $487,000 | +170.6% | 61,013 | +235.0% | 0.07% | +250.0% |
| Q2 2020 | $180,000 | +133.8% | 18,215 | +81.9% | 0.02% | +81.8% |
| Q1 2020 | $77,000 | +14.9% | 10,016 | -42.3% | 0.01% | +175.0% |
| Q4 2019 | $67,000 | -81.2% | 17,364 | -75.5% | 0.00% | -77.8% |
| Q3 2019 | $356,000 | – | 70,843 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 964,141 | $7,829,000 | 1.90% |
| Skylands Capital, LLC | 1,837,541 | $14,921,000 | 1.84% |
| CM Management, LLC | 175,000 | $1,421,000 | 1.06% |
| Soleus Capital Management, L.P. | 800,000 | $6,496,000 | 1.01% |
| Avenir Corp | 1,395,385 | $11,331,000 | 0.95% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,502,000 | 0.55% |
| Winning Points Advisors, LLC | 86,200 | $701,000 | 0.51% |
| Granahan Investment Management | 1,154,561 | $9,375,000 | 0.18% |
| SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,987,000 | 0.16% |
| Redmile Group, LLC | 1,044,434 | $8,481,000 | 0.15% |